Sign in / Join Now
ETFs & Funds
Bearish call on $
, 3k patient cannot generate 775 million in 2015. Its a sell with
Add a reply...
Latest StockTalks »
people get BMRN breaking news and analysis by email alert.
Get email alerts on BMRN »
BioMarin Pharmaceutical Inc.
Get latest price
From other sites
FDA Accepts BLA For BioMarin's Cerliponase Alfa For CLN2 Disease, Form Of Batten Disease
at TheStreet (Wed, 6:02PM)
Biomarin Hemophilia Gene Therapy Advances on Strong Study Results
at TheStreet (Wed, 3:47PM)
BioMarin Provides Positive Proof-of-Concept Data For BMN 270 Gene Therapy In Hemophilia A In Late Breaking Oral Presentation At The World Federation Of Hemophilia (WFH) 2016 World Congress
at TheStreet (Wed, 2:30PM)
Can The Uptrend Continue for with BioMarin Pharmaceutical (BMRN)?
at Zacks.com (Jul 19, 2016)
BioMarin Pharmaceutical (BMRN) Jumps: Stock Rises 9.1%
at Zacks.com (Jul 8, 2016)